Profiling the immune vulnerability landscape of the 2019 Novel Coronavirus
Zhu, J.; Kim, J.; Xiao, X.; Wang, Y.; Luo, D.; Chen, R.; Xu, L.; Zhang, H.; Xiao, G.; Zhan, X.; Wang, T.; Xie, Y.
Show abstract
The outbreak of the 2019 Novel Coronavirus (SARS-CoV-2) rapidly spread from Wuhan, China to more than 150 countries, areas, or territories, causing staggering numbers of infections and deaths. In this study, bioinformatics analyses were performed on 5,568 complete genomes of SARS-CoV-2 virus to predict the T cell and B cell immunogenic epitopes of all viral proteins, which formed a systematic immune vulnerability landscape of SARS-CoV-2. The immune vulnerability and genetic variation profiles of SARS-CoV were compared with those of SARS-CoV and MERS-CoV. In addition, a web portal was developed to broadly share the data and results as a resource for the research community. Using this resource, we showed that genetic variations in SARS-CoV-2 are associated with loss of B cell immunogenicity, an increase in CD4+ T cell immunogenicity, and a minimum loss in CD8+ T cell immunogenicity, indicating the existence of a curious correlation between SARS-CoV-2 genetic evolutions and the immunity pressure from the host. Overall, we present an immunological resource for SARS-CoV-2 that could promote both therapeutic/vaccine development and mechanistic research.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene 94%
- Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity 94%
- Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 94%
Similar papers in this journal
- AIVE: accurate predictions of SARS-CoV-2 infectivity from comprehensive analysis 95%
- Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus 95%
- Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms 94%
Similar papers in this journal
Similar papers in this journal
- Intra-host evolution during SARS-CoV-2 persistent infection 96%
- Unique protein features of SARS-CoV-2 relative to other Sarbecoviruses 95%
- Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.